Cellulose-based medicine tablet and preparation method thereof
By heating the microcrystalline cellulose and hydrogen peroxide solution to form cellulose nanocrystalline, combined with wet and dry preparation methods, the shortcomings of traditional pharmaceutical excipients in nanoscale particle size and biocompatibility are solved, and the High drug loading rate and rapid disintegration of cellulose-based drug tablets improve the stability and safety of drug preparations.
Patent Information
- Application Number
- CN202410987824.6
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-07-23
- Publication Date
- 2024-11-12
AI Technical Summary
Traditional medicinal excipients are difficult to provide nano-scale particle size and good biocompatibility, and dust generated during dry granulation affects operation safety, wet granulation process is complicated and it is difficult to control particle size distribution, which cannot meet the multi-function of modern pharmaceutical preparations. The demand for auxiliary materials.
Cellulose-based drug tablets are prepared by heating with microcrystalline cellulose and hydrogen peroxide solution. .
It achieves high drug loading rate, rapid disintegration, good bioavailability and stability, avoids dust problems and particle size distribution difficulties, and improves the physical characteristics and safety of drug preparations.
Smart Images

Figure CN118924906A_ABST
Abstract
Description
Technical Field
[0001] The invention belongs to the technical field of biomedicine, and in particular relates to a cellulose-based drug tablet and a preparation method thereof. Background Art
[0002] Pharmaceutical excipients play a vital role in drug preparations. They not only affect the physical and chemical properties of drugs, but also directly affect the stability, bioavailability, safety and therapeutic effects of drugs. However, traditional pharmaceutical excipients have many problems, such as difficulty in providing the required nanoscale particle size and good biocompatibility, or can only provide one or a few functions, which cannot meet the needs of modern drug preparations for multifunctional excipients. One of the most effective solutions is to develop a natural, multifunctional nanofiber excipient to improve biocompatibility and replace traditional pharmaceutical excipients. Cellulose nanocrystals have the advantages of high specific surface area, good biocompatibility, and can be used as a multifunctional carrier, so they have unlimited potential in pharmaceutical excipients.
[0003] Traditional granulation methods usually include two main methods: dry granulation and wet granulation. During the dry granulation process, a large amount of dust is generated when the powdered drug is compressed and crushed by the machine. This dust not only affects the cleanliness and safety of the operating environment, but may also affect the health of the operator. In particular, long-term exposure to dust may cause respiratory problems. In addition, since there is no liquid involved when the particles are formed during the dry granulation process, it is difficult to achieve precise particle size and distribution control. The binder added during the wet granulation preparation process can not only make the hydrophobic drug surface hydrophilic but also prevent powder separation, improve the fluidity and compressibility of the particles, and increase the particle density.
[0004] Popular health care products on the market, such as vitamin A and vitamin D, if dry granulation is used, the mixed powder is directly put into a tablet press and pressed into tablets or granules of fixed shape under high pressure. However, since no binder or solvent is added in dry granulation, the resulting tablets may be relatively loose or less dense, which will eventually lead to powder accumulation on the tablet surface, affecting the taste. The wet granulation method has complex procedures and slow production speed, and the final particle size distribution of the particles is wide, making it difficult to control the particle size. Some drug ingredients are sensitive to moisture and heat and may degrade during the wet granulation process. Compared with pure wet granulation, dry-wet mixing requires less liquid for granulation and saves resources. Since it reduces drying time and temperature exposure, it is more suitable for heat-sensitive drugs. Dry-wet mixing granulation usually requires less adhesive or other granulating agents, thereby reducing the potential impact of additives on drug activity and eliminating steps such as screening in wet granulation. Water is added as a binder in the intermediate step, which also avoids problems such as dust caused by dry granulation. Through dry-wet mixing granulation, the advantages of dry and wet methods can be combined to prepare solid preparations with good physical properties and bioavailability. Summary of the invention
[0005] Based on the above-mentioned shortcomings and deficiencies in the prior art, one of the objects of the present invention is to at least solve one or more of the above-mentioned problems in the prior art. In other words, one of the objects of the present invention is to provide a cellulose-based pharmaceutical tablet and a preparation method thereof that meet one or more of the above-mentioned needs.
[0006] In order to achieve the above-mentioned object of the invention, the present invention adopts the following technical solutions:
[0007] A method for preparing a cellulose-based pharmaceutical tablet comprises the following steps:
[0008] (1) adding microcrystalline cellulose to a hydrogen peroxide solution, heating the mixture at 60-90° C. for 6-9 hours, cooling the mixture to room temperature, heating, screening, and spray drying to obtain cellulose nanocrystals;
[0009] (2) mixing cellulose nanocrystals and drugs uniformly, then adding deionized water and stirring continuously until wet aggregates are formed;
[0010] (3) drying the agglomerates, grinding the dried particles into powder, and finally pressing them into tablets to obtain cellulose-based drug tablets.
[0011] As a preferred embodiment, in step (1), the solid-liquid ratio of microcrystalline cellulose to hydrogen peroxide solution is 1 g:30-50 mL, and the concentration of hydrogen peroxide solution is 20-40 wt %.
[0012] As a preferred embodiment, in step (1), the temperature of the heating and screening is 50-60°C.
[0013] As a preferred embodiment, in step (2), the drug is a Chinese medicine extract or a Western medicine active molecule.
[0014] As a preferred embodiment, the Chinese medicine extract is Lysimachia scabra extract, Tianguiqingying granules dry paste powder or Astragalus extract.
[0015] As a preferred embodiment, the active molecule of western medicine is tetracycline hydrochloride, azithromycin or monascus.
[0016] As a preferred embodiment, in step (2), the mass ratio of cellulose nanocrystals to drugs is 1:0.5-1, and the solid-liquid ratio of the total amount of cellulose nanocrystals and drugs to deionized water is 1g:5-10mL.
[0017] As a preferred embodiment, in step (3), the drying temperature is 50-60°C.
[0018] As a preferred embodiment, in step (3), the tableting pressure is 15-20 kN.
[0019] The present invention also provides a cellulose-based pharmaceutical tablet prepared by the preparation method described in any of the above schemes.
[0020] Compared with the prior art, the present invention has the following beneficial effects:
[0021] The present invention uses cellulose nanocrystals CNC as drug excipients and Chinese medicine extracts or western medicine active molecules as main drugs, and prepares drug tablets by combining wet and dry methods; wherein, cellulose nanocrystals have a high specific surface area, and thus can provide more active sites, and can also improve the drug loading capacity and bioavailability; cellulose nanocrystals have stable chemical properties, are not prone to degradation or deterioration, and ensure the stability of drug preparations and other advantages.
[0022] The pharmaceutical tablet of the present invention has the advantages of high drug loading rate, high water retention, small volume and fast disintegration, and can be widely used in the fields of biomedicine and the like. BRIEF DESCRIPTION OF THE DRAWINGS
[0023] Figure 1 The scanning electron microscope photos and magnified images, and particle size distribution diagram of cellulose nanocrystals CNC and microcrystalline cellulose MCC of Examples 1 and 2 of the present invention;
[0024] Figure 2 This is a comparison chart of drug loading rates of drug tablets made of cellulose nanocrystals CNC and microcrystalline cellulose MCC according to Examples 1 and 2 of the present invention;
[0025] Figure 3This is a comparison chart of the hardness of the pharmaceutical tablets made of cellulose nanocrystals CNC and microcrystalline cellulose MCC according to Examples 1 and 2 of the present invention;
[0026] Figure 4 It is a static drug release state diagram of the tablets of Example 2, Comparative Example 1 and Comparative Example 2 of the present invention. DETAILED DESCRIPTION
[0027] The technical solution of the present invention is further explained below by way of examples.
[0028] Embodiment 1:
[0029] The method for preparing the pharmaceutical tablets of this embodiment comprises the following steps:
[0030] 1 g of microcrystalline cellulose MCC was added to 50 mL of a 30 wt% hydrogen peroxide solution, and the mixture was placed in a 60° water bath and heated for 6 hours. After the mixture was cooled to room temperature, it was heated at 50°C, sieved, and spray-dried to obtain cellulose nanocrystals CNC.
[0031] Cellulose nanocrystals CNC and tetracycline hydrochloride were uniformly mixed in a mass ratio of 3:2 to obtain 2 g of the mixture, and then 15 mL of deionized water was added. The mixture was continuously stirred with a stirrer until moist agglomerates were formed. The agglomerates were then placed in an oven at 60°C for drying. The dried particles were then ground into powder and finally sent to a high-pressure tablet press. The mixed powder was pressed into tablets using a physical pressure of 15 kN, referred to as CNCs-6h.
[0032] Embodiment 2:
[0033] The method for preparing the pharmaceutical tablets of this embodiment comprises the following steps:
[0034] 1 g of microcrystalline cellulose was added to 50 mL of a 30 wt% hydrogen peroxide solution, and the mixture was placed in a 60° water bath and heated for 9 hours. After the mixture was cooled to room temperature, it was heated at 50°C, sieved, and spray-dried to obtain cellulose nanocrystals CNC;
[0035] Cellulose nanocrystals CNC and tetracycline hydrochloride were uniformly mixed in a mass ratio of 3:2 to obtain 2 g of the mixture, and then 15 mL of deionized water was added and stirred continuously with a stirrer until moist agglomerates were formed. The agglomerates were then placed in an oven at 60 °C for drying, and the dried particles were ground into powder. Finally, they were sent to a high-pressure tablet press and the mixed powder was pressed into tablets by a physical pressure of 15 kN, referred to as CNCs-9h.
[0036] Embodiment 3:
[0037] The method for preparing the pharmaceutical tablets of this embodiment comprises the following steps:
[0038] 1 g of microcrystalline cellulose was added to 40 mL of a 20 wt% hydrogen peroxide solution, and the mixture was placed in an 80°C water bath and heated for 7 hours. After the mixture was cooled to room temperature, it was heated at 60°C, sieved, and spray-dried to obtain cellulose nanocrystals CNC;
[0039] Cellulose nanocrystals CNC and azithromycin were uniformly mixed in a mass ratio of 1:1 to obtain 2 g of a mixture, and then 10 mL of deionized water was added and stirred continuously with a stirrer until moist agglomerates were formed. The agglomerates were then placed in an oven at 60°C for drying, and the dried particles were ground into powder. Finally, the mixture was sent to a high-pressure tablet press and the mixed powder was pressed into tablets by a physical pressure of 20 kN.
[0040] Embodiment 4:
[0041] The method for preparing the pharmaceutical tablets of this embodiment comprises the following steps:
[0042] 1 g of microcrystalline cellulose was added to 50 mL of 40 wt% hydrogen peroxide solution, and the mixture was placed in a 90°C water bath and heated for 8 hours. After the mixture was cooled to room temperature, it was heated at 55°C, sieved, and spray-dried to obtain cellulose nanocrystals CNC;
[0043] Cellulose nanocrystals CNC and monascus were uniformly mixed in a mass ratio of 1:0.5 to obtain 2 g of a mixture, and then 20 mL of deionized water was added. The mixture was continuously stirred with a stirrer until a moist agglomerate was formed. The agglomerate was then placed in an oven at 55°C for drying. The dried particles were then ground into powder and finally sent to a high-pressure tablet press to press the mixed powder into tablets using a physical pressure of 18 kN.
[0044] Embodiment 5:
[0045] The method for preparing the pharmaceutical tablets of this embodiment comprises the following steps:
[0046] 1 g of microcrystalline cellulose was added to 50 mL of 35 wt% hydrogen peroxide solution, and the mixture was placed in a water bath at 85°C and heated for 6.5 hours. After the mixture was cooled to room temperature, it was heated at 50°C, sieved, and spray-dried to obtain cellulose nanocrystals CNC;
[0047] Take 5 g of Lysimachia chinensis, add water and boil three times, each time for 1 hour, combine the decoctions, filter, and concentrate the filtrate to a relative density of 1.45, add nanocellulose crystals CNC, and use a stirrer to stir continuously until moist agglomerates are formed. Then put the agglomerates into an oven at 60°C until they are dry, and then grind the dried particles into powder, and finally send them to a high-pressure tablet press, and press the mixed powder into tablets by a physical pressure of 15 kN.
[0048] Embodiment 6:
[0049] The method for preparing the pharmaceutical tablets of this embodiment comprises the following steps:
[0050] 1 g of microcrystalline cellulose was added to 40 mL of 35 wt% hydrogen peroxide solution, and the mixture was placed in a 75°C water bath and heated for 7.5 hours. After the mixture was cooled to room temperature, it was heated at 60°C, sieved, and spray-dried to obtain cellulose nanocrystals CNC;
[0051] Cellulose nanocrystals CNC and Tianguiqingying granules dry powder were uniformly mixed in a mass ratio of 1:0.8 to obtain 2 g of the mixture, and then 18 mL of deionized water was added. The mixture was continuously stirred with a stirrer until a moist agglomerate was formed. The agglomerate was then placed in an oven at 60°C until dry. The dried particles were then ground into powder and finally sent to a high-pressure tablet press to press the mixed powder into tablets using a physical pressure of 16 kN.
[0052] Embodiment 7:
[0053] The method for preparing the pharmaceutical tablets of this embodiment comprises the following steps:
[0054] 1 g of microcrystalline cellulose was added to 45 mL of 30 wt% hydrogen peroxide solution, and the mixture was placed in a 65°C water bath and heated for 6 hours. After the mixture was cooled to room temperature, it was heated at 55°C, sieved, and spray-dried to obtain cellulose nanocrystals CNC;
[0055] Grind the Astragalus into powder, then evenly mix the cellulose nanocrystals and Astragalus powder in a mass ratio of 3:2 to obtain 2 g of the mixture, then add 14 mL of deionized water, and stir continuously with a stirrer until moist agglomerates are formed. Then, place the agglomerates in an oven at 55°C and dry them. Then, grind the dried particles into powder, and finally send them into a high-pressure tablet press to press the mixed powder into tablets using a physical pressure of 15 kN.
[0056] Comparative Example 1:
[0057] The difference between this comparative example and Example 2 is that no binder is added to the uniformly mixed powder and the powder is directly tableted.
[0058] The preparation method of the pharmaceutical tablets of this embodiment is a dry method, comprising the following steps:
[0059] 1 g of microcrystalline cellulose was added to 50 mL of a 30 wt% hydrogen peroxide solution, and the mixture was placed in a 60° water bath and heated for 6 hours. After the mixture was cooled to room temperature, it was heated at 50°C, sieved, and spray-dried to obtain cellulose nanocrystals CNC;
[0060] Cellulose nanocrystals CNC and tetracycline hydrochloride were uniformly mixed in a mass ratio of 3:2 to obtain 2 g of the mixture, which was fed into a high-pressure tablet press and pressed into tablets by a physical pressure of 15 kN.
[0061] Comparative Example 2:
[0062] The difference between this comparative example and Example 2 is that the soft material needs to be passed through a granulator to form uniform wet granules, a sieve or extrusion method is used to form granules of uniform particle size, and the dried granules need to be granulated to obtain granules of uniform particle size. Granulation is usually performed by a sieve or a pulverizing device.
[0063] The preparation method of the pharmaceutical tablets of this comparative example is a wet method, comprising the following steps:
[0064] 1 g of microcrystalline cellulose was added to 50 mL of a 30 wt% hydrogen peroxide solution, and the mixture was placed in a 60° water bath and heated for 6 hours. After the mixture was cooled to room temperature, it was heated at 50°C, sieved, and spray-dried to obtain cellulose nanocrystals CNC;
[0065] Cellulose nanocrystals CNC and tetracycline hydrochloride are uniformly mixed in a mass ratio of 3:2 to obtain 2 g of a mixture, and the binder solution is gradually added to the mixed powder while stirring to make the powder uniformly moistened to form a moist soft material, and the soft material is passed through a granulator to form uniform wet granules, and the wet granules are dried in an oven at an appropriate temperature, and the dried granules are granulated through a sieve or a pulverizing device to obtain granules with uniform particle size, and the other steps are the same as those in Example 2.
[0066] As attached Figure 1 As shown in the UV spectrophotometer (UV) test graph, Example 1 successfully prepared a cellulose-based pharmaceutical excipient wet granulation tablet based on high-efficiency loading of Chinese and Western medicines. The drug loading rate of cellulose-based excipients of different sizes was different. As the size decreased, the drug loading rate continued to increase. The drug loading rate of CNCs-9h tablets was the highest, reaching 88.6%. Figure 2 The hardness of CNCs-9h tablets was higher than that of MCC and CNCs-6h. The hardness of CNCs-9h tablets was 90.24N. Figure 3 The static drug release of cellulose-based pharmaceutical excipients wet granulated into tablets based on high-efficiency loading of Chinese and Western medicines is shown in the figure, among which CNCs-9h has the fastest drug release. This shows that cellulose-based excipients have excellent release performance; as shown in the attached Figure 4Based on the static disintegration diagram of wet granulation of cellulose-based pharmaceutical excipients with high efficiency in loading Chinese and Western medicines, the disintegration time of dry granulation is the slowest, at 30 minutes, only a few tablets on the surface are cracked, the disintegration time of wet granulation is second, at 30 minutes, the tablet is completely disintegrated, and the dry and wet mixed granulation of Example 2 is within 15 minutes, and the cellulose tablet is completely disintegrated. High drug loading rate, high water retention, small volume, and fast disintegration are the excellent properties of cellulose-based tablets.
[0067] In view of the numerous embodiments of the scheme of the present invention, the raw materials and dosage involved can be selected according to actual needs within the limited range, and the experimental data of each embodiment is huge and numerous, which is not suitable for listing and explaining one by one here, but the content required to be verified and the final conclusion obtained in each embodiment are similar. Therefore, the verification content of each embodiment will not be explained one by one here.
[0068] The above description is only a detailed description of the preferred embodiments and principles of the present invention. For ordinary technicians in this field, according to the ideas provided by the present invention, there will be changes in the specific implementation methods, and these changes should also be regarded as the protection scope of the present invention.
Claims
1. A method for preparing a cellulose-based pharmaceutical tablet, characterized in that: The following steps are involved: (1) adding microcrystalline cellulose to a hydrogen peroxide solution, heating the mixture at 60-90° C. for 6-9 hours, cooling the mixture to room temperature, heating, screening, and spray drying to obtain cellulose nanocrystals; (2) mixing cellulose nanocrystals and drugs uniformly, then adding deionized water and stirring continuously until wet aggregates are formed; (3) drying the agglomerates, grinding the dried particles into powder, and finally pressing them into tablets to obtain cellulose-based drug tablets.
2. The preparation method according to claim 1, characterized in that: In the step (1), the solid-liquid ratio of microcrystalline cellulose to hydrogen peroxide solution is 1 g:30-50 mL, and the concentration of hydrogen peroxide solution is 20-40 wt %.
3. The preparation method according to claim 1, characterized in that: In the step (1), the temperature of the heating and screening is 50-60°C.
4. The preparation method according to claim 1, characterized in that: In the step (2), the drug is a Chinese medicine extract or an active molecule of a Western medicine.
5. The preparation method according to claim 4, characterized in that: The Chinese medicine extract is Lysimachia chinensis extract, Tianguiqingying granule dry paste powder or Astragalus extract.
6. The preparation method according to claim 4, characterized in that: The western medicine active molecule is tetracycline hydrochloride, azithromycin or monascus.
7. The preparation method according to claim 1, characterized in that: In the step (2), the mass ratio of cellulose nanocrystals to drugs is 1:0.5-1, and the solid-liquid ratio of the total amount of cellulose nanocrystals and drugs to deionized water is 1g:5-10mL.
8. The preparation method according to claim 1, characterized in that: In the step (3), the drying temperature is 50-60°C.
9. The preparation method according to claim 1, characterized in that: In the step (3), the tableting pressure is 15-20 kN.
10. A cellulose-based pharmaceutical tablet prepared according to the preparation method according to any one of claims 1 to 9.
